Suparma Tbk PT
IDX:SPMA

Watchlist Manager
Suparma Tbk PT Logo
Suparma Tbk PT
IDX:SPMA
Watchlist
Price: 304 IDR 0.66%
Market Cap: 958.8B IDR
Have any thoughts about
Suparma Tbk PT?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

2.6T
+0.6%
Revenue
Growth Rates:
1 Year
-9%
3 Years
+11%
5 Years
+4%
7 Years
+35%
10 Years
+81%
239.5B
+2%
Operating Income
Growth Rates:
1 Year
-51%
3 Years
-6%
5 Years
+16%
7 Years
+25%
10 Years
+98%
108.3B
-10%
Net Income
Growth Rates:
1 Year
-68%
3 Years
-37%
5 Years
-14%
7 Years
+21%
10 Years
-

Earnings Waterfall
Suparma Tbk PT

Revenue
2.6T IDR
Cost of Revenue
-2.2T IDR
Gross Profit
451.5B IDR
Operating Expenses
-211.9B IDR
Operating Income
239.5B IDR
Other Expenses
-131.3B IDR
Net Income
108.3B IDR

Income Statement
Suparma Tbk PT

Rotate your device to view
Income Statement
Currency: IDR
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
1 457 672
N/A
1 492 166
+2%
1 550 810
+4%
1 567 709
+1%
1 588 003
+1%
1 584 271
0%
1 621 516
+2%
1 725 075
+6%
1 794 204
+4%
1 878 815
+5%
1 932 435
+3%
1 925 010
0%
1 947 588
+1%
2 051 568
+5%
2 093 138
+2%
2 173 852
+4%
2 207 398
+2%
2 263 627
+3%
2 389 269
+6%
2 455 059
+3%
2 541 571
+4%
2 571 023
+1%
2 514 161
-2%
2 465 383
-2%
2 270 052
-8%
2 175 571
-4%
2 151 495
-1%
2 189 270
+2%
2 375 421
+9%
2 537 266
+7%
2 794 453
+10%
2 961 596
+6%
3 122 634
+5%
3 227 563
+3%
3 138 054
-3%
3 071 671
-2%
2 896 721
-6%
2 732 350
-6%
2 658 521
-3%
2 617 370
-2%
2 632 555
+1%
Gross Profit
Cost of Revenue
(1 227 258)
(1 258 855)
(1 289 878)
(1 294 148)
(1 303 126)
(1 283 519)
(1 369 699)
(1 450 940)
(1 498 193)
(1 596 655)
(1 620 898)
(1 622 117)
(1 634 800)
(1 751 159)
(1 777 790)
(1 857 033)
(1 880 168)
(1 898 690)
(2 016 339)
(2 071 542)
(2 164 078)
(2 195 705)
(2 139 362)
(2 091 143)
(1 906 157)
(1 793 540)
(1 758 714)
(1 772 993)
(1 953 186)
(2 026 142)
(2 205 297)
(2 323 364)
(2 457 885)
(2 513 282)
(2 419 296)
(2 375 187)
(2 218 416)
(2 185 779)
(2 187 911)
(2 166 085)
(2 181 069)
Gross Profit
230 415
N/A
233 311
+1%
260 932
+12%
273 561
+5%
284 877
+4%
300 752
+6%
251 817
-16%
274 135
+9%
296 011
+8%
282 160
-5%
311 537
+10%
302 893
-3%
312 787
+3%
300 408
-4%
315 347
+5%
316 818
+0%
327 230
+3%
364 937
+12%
372 930
+2%
383 517
+3%
377 494
-2%
375 318
-1%
374 799
0%
374 240
0%
363 895
-3%
382 031
+5%
392 781
+3%
416 277
+6%
422 235
+1%
511 124
+21%
589 156
+15%
638 231
+8%
664 748
+4%
714 280
+7%
718 758
+1%
696 483
-3%
678 305
-3%
546 571
-19%
470 610
-14%
451 286
-4%
451 485
+0%
Operating Income
Operating Expenses
(109 534)
(114 882)
(118 266)
(125 285)
(128 278)
(132 256)
(131 887)
(131 588)
(159 061)
(153 096)
(145 507)
(145 250)
(121 197)
(127 112)
(131 502)
(133 686)
(136 216)
(145 681)
(159 036)
(164 604)
(170 781)
(169 061)
(186 892)
(188 937)
(180 267)
(177 054)
(153 935)
(159 075)
(167 454)
(173 952)
(177 541)
(179 344)
(183 319)
(185 411)
(180 371)
(187 427)
(187 546)
(190 206)
(211 906)
(215 624)
(211 937)
Selling, General & Administrative
(107 530)
(112 553)
(116 535)
(123 149)
(126 252)
(130 412)
(130 500)
(130 445)
(142 527)
(136 755)
(134 873)
(135 640)
(129 163)
(136 202)
(137 852)
(138 860)
(137 840)
(146 194)
(158 857)
(164 058)
(174 153)
(171 535)
(176 589)
(180 166)
(172 264)
(165 523)
(157 891)
(163 506)
(171 059)
(179 866)
(177 654)
(178 592)
(183 069)
(185 282)
(188 540)
(195 650)
(195 938)
(201 257)
(211 377)
(215 481)
(212 780)
Depreciation & Amortization
(3 003)
(3 118)
(3 203)
(3 288)
(3 422)
(3 619)
(3 836)
(4 011)
(4 142)
(4 246)
(4 353)
(4 440)
(4 495)
(4 456)
(4 337)
(4 182)
(3 995)
(3 831)
(3 719)
(3 586)
(3 527)
(3 500)
(3 443)
(3 280)
(3 103)
(2 982)
(3 266)
(3 277)
(3 391)
(3 593)
(3 289)
(3 453)
(3 534)
(3 550)
(3 737)
(3 914)
(4 109)
(4 243)
(4 170)
(4 232)
(4 235)
Other Operating Expenses
999
789
1 472
1 152
1 396
1 775
2 450
2 866
(12 393)
(12 094)
(6 281)
(5 169)
12 462
13 546
10 687
9 356
5 619
4 344
3 540
3 040
6 899
5 974
(6 861)
(5 491)
(4 900)
(8 549)
7 223
7 707
6 995
9 507
3 402
2 701
3 285
3 421
11 905
12 138
12 501
15 294
3 641
4 088
5 078
Operating Income
120 880
N/A
118 430
-2%
142 666
+20%
148 277
+4%
156 600
+6%
168 495
+8%
119 930
-29%
142 546
+19%
136 949
-4%
129 064
-6%
166 029
+29%
157 643
-5%
191 591
+22%
173 297
-10%
183 846
+6%
183 132
0%
191 013
+4%
219 255
+15%
213 894
-2%
218 912
+2%
206 712
-6%
206 257
0%
187 907
-9%
185 303
-1%
183 628
-1%
204 977
+12%
238 846
+17%
257 202
+8%
254 781
-1%
337 172
+32%
411 615
+22%
458 888
+11%
481 429
+5%
528 869
+10%
538 387
+2%
509 057
-5%
490 758
-4%
356 365
-27%
258 704
-27%
235 661
-9%
239 548
+2%
Pre-Tax Income
Interest Income Expense
(152 407)
(137 682)
(77 365)
(162 659)
(129 836)
(220 134)
(176 746)
(105 089)
(109 032)
(883)
(54 671)
(74 545)
(70 033)
(80 996)
(61 672)
(81 092)
(114 890)
(128 915)
(99 668)
(71 983)
(37 527)
(6 881)
(18 878)
(99 365)
(25 541)
(55 588)
(38 312)
19 373
(44 984)
(5 537)
(32 119)
(21 256)
(45 218)
(72 940)
(102 660)
(70 857)
(49 563)
(53 659)
(18 017)
(65 522)
(87 657)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2 394
0
(2 394)
(2 394)
(4 789)
(4 789)
0
0
0
0
0
0
0
0
0
0
0
0
0
187
0
0
Total Other Income
0
0
0
0
0
1
0
2
2
2
0
1
1
1
(865)
(96)
(3 768)
(3 910)
(4 552)
(4 607)
(936)
(1 665)
(1 560)
(2 245)
(5 875)
(5 451)
(5 031)
(5 253)
(2 019)
(2 490)
(1 986)
(1 929)
(1 825)
(3 810)
(4 281)
(4 267)
(4 705)
(3 370)
(3 025)
(5 477)
(5 210)
Pre-Tax Income
(31 527)
N/A
(19 252)
+39%
65 301
N/A
(14 382)
N/A
26 764
N/A
(51 638)
N/A
(56 816)
-10%
37 459
N/A
27 919
-25%
128 183
+359%
111 358
-13%
83 099
-25%
121 559
+46%
92 302
-24%
121 309
+31%
101 944
-16%
72 355
-29%
86 430
+19%
109 673
+27%
144 715
+32%
168 249
+16%
195 317
+16%
165 074
-15%
78 904
-52%
147 423
+87%
143 938
-2%
195 503
+36%
271 321
+39%
207 779
-23%
329 145
+58%
377 510
+15%
435 702
+15%
434 387
0%
452 119
+4%
431 446
-5%
433 932
+1%
436 490
+1%
299 336
-31%
237 849
-21%
164 662
-31%
146 681
-11%
Net Income
Tax Provision
7 877
4 722
(16 699)
(10 065)
(7 048)
12 435
14 219
(9 291)
(6 819)
(35 475)
(30 295)
(22 956)
(32 250)
(20 868)
(29 029)
(24 523)
(17 419)
(21 302)
(27 441)
(36 198)
(42 269)
(49 003)
(45 635)
(23 890)
(38 618)
(37 422)
(32 979)
(50 888)
(35 945)
(62 085)
(83 184)
(95 883)
(95 525)
(99 522)
(95 308)
(95 729)
(96 528)
(65 909)
(59 190)
(44 327)
(38 413)
Income from Continuing Operations
(23 649)
(14 529)
48 603
(24 447)
19 715
(39 204)
(42 597)
28 167
21 099
92 706
81 063
60 142
89 309
71 435
92 280
77 422
54 937
65 130
82 233
108 518
125 980
146 314
119 439
55 014
108 806
106 517
162 525
220 433
171 833
267 060
294 326
339 819
338 862
352 597
336 138
338 203
339 963
233 426
178 658
120 336
108 268
Net Income (Common)
(23 649)
N/A
(14 529)
+39%
48 603
N/A
(24 447)
N/A
19 715
N/A
(39 204)
N/A
(42 597)
-9%
28 167
N/A
21 099
-25%
92 706
+339%
81 063
-13%
60 142
-26%
89 309
+48%
71 435
-20%
92 280
+29%
77 422
-16%
54 937
-29%
65 130
+19%
82 233
+26%
108 518
+32%
125 980
+16%
146 314
+16%
119 439
-18%
55 014
-54%
108 806
+98%
106 517
-2%
162 525
+53%
220 433
+36%
171 833
-22%
267 060
+55%
294 326
+10%
339 819
+15%
338 862
0%
352 597
+4%
336 138
-5%
338 203
+1%
339 963
+1%
233 426
-31%
178 658
-23%
120 336
-33%
108 268
-10%
EPS (Diluted)
-15.85
N/A
-9.74
+39%
32.57
N/A
-16.39
N/A
13.21
N/A
-26.27
N/A
-28.55
-9%
18.88
N/A
14.15
-25%
62.14
+339%
35.77
-42%
28.43
-21%
42.22
+49%
33.77
-20%
29.26
-13%
36.6
+25%
25.98
-29%
30.8
+19%
26.07
-15%
51.32
+97%
59.58
+16%
69.19
+16%
37.87
-45%
19.7
-48%
38.98
+98%
38.16
-2%
51.53
+35%
69.88
+36%
54.48
-22%
164.35
+202%
107.12
-35%
123.67
+15%
117.25
-5%
115.14
-2%
106.57
-7%
107.22
+1%
107.78
+1%
73.99
-31%
56.64
-23%
38.15
-33%
34.33
-10%

See Also

Summary
SPMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SPMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SPMA stock valuation using valuation multiples.
Wall Street Estimates
SPMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SPMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.